Article citationsMore>>

Zamarin, D., Burger, R.A., Sill, M.W., Powell Jr., D.J., Lankes, H.A., Feldman, M.D., et al. (2020) Randomized Phase II Trial of Nivolumab versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38, 1814-1823.
https://doi.org/10.1200/JCO.19.02059

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top